Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model

Tamer M Said, Ashok Agarwal, Tommaso Falcone, Rakesh K Sharma, Rakesh Sharma, Mohamed A Bedaiwy, Liang Li
Fertility and sterility · 2005 · vol. 83(6) , pp. 1665–1673 · doi:10.1016/j.fertnstert.2004.11.068 · PMID:15950634 · W2107994883
article OA: closed CC0 ⤵ 21 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study used an in vitro model to investigate if infliximab could reverse the toxic effects of tumor necrosis factor alpha on human spermatozoa.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Antibodies, Monoclonal Tumor Necrosis Factor-alpha Tumor Necrosis Factor-alpha Analysis of Variance Antibodies, Monoclonal DNA Fragmentation DNA Fragmentation Dose-Response Relationship, Immunologic Humans Infliximab Male Prospective Studies Spermatozoa Spermatozoa Sperm Motility Sperm Motility Time Factors Tumor Necrosis Factor-alpha

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (57)

Cited by (21)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:35.797702+00:00
License: CC0 · commercial use OK